Yayınlar & Eserler

Yayın Ağı
Makaleler 31
Tümü (31)
SCI-E, SSCI, AHCI (29)
SCI-E, SSCI, AHCI, ESCI (30)
ESCI (1)
Scopus (30)
TRDizin (1)

1. Early response is a strong predictor of the long-term response in psoriasis patients receiving risankizumab or guselkumab in the real-world: a retrospective analysis

AKDOĞAN N., MUTLU Ö. K., KARABULUT E., YALICI ARMAĞAN B., GÜLSEREN D., DOĞAN GÜNAYDIN S.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY , cilt.18, sa.6, ss.417-423, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

2. Identifying epidermolysis bullosa subtypes through immune antigenic mapping in Turkish patients

DOĞAN GÜNAYDIN S., GÖKÖZ Ö., YALICI ARMAĞAN B., ERSOY EVANS S.
JOURNAL OF CUTANEOUS PATHOLOGY , cilt.51, ss.725-731, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

3. Psoriatic arthritis, biologic therapy experience, body mass index, and onset age of psoriasis were independent factors of secukinumab discontinuation in patients with psoriasis

AKDOĞAN N., Balan K., YALICI ARMAĞAN B., GÜLSEREN D., DOĞAN GÜNAYDIN S.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY , cilt.17, sa.8, ss.755-762, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

4. Impact of COVID-19 Pandemic on Hidradenitis Suppurativa Patients: a Cross-Sectional Study From Tertiary Referral Hospital

Bostan E., Jarbou A., KARADUMAN A., GÜLSEREN D., YALICI ARMAĞAN B., AKDOĞAN N.
Dermatology Practical and Conceptual , cilt.12, sa.4, 2022 (SCI-Expanded, Scopus) Creative Commons License identifier identifier

5. Diagnostic Role of Direct Immunofluorescence Assay in Determining The Etiology of Erythroderma: Experience in a Tertiary Referral Hospital

Bostan E., GÖKÖZ Ö., Dogan S., GÜLSEREN D., AKDOĞAN N., YALICI ARMAĞAN B., et al.
Dermatology Practical and Conceptual , cilt.12, sa.4, 2022 (SCI-Expanded, Scopus) Creative Commons License identifier identifier

6. Evaluation of Diagnostic Accuracy and Therapeutic Approach of Dermatologists and Plastic Surgeons To Non-Melanocytic Skin Lesions By Using Telemedicine

Tugrul B., YALICI ARMAĞAN B., Demirdag H. G., Gunduz O.
Dermatology Practical and Conceptual , cilt.12, sa.3, 2022 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

7. Unusual Presentation of Kaposi Sarcoma During Adalimumab Therapy: a Case Report

Tabak G., YALICI ARMAĞAN B., Sahin B., GÖKÖZ Ö., KİRAZ S.
Dermatology Practical and Conceptual , cilt.12, sa.3, 2022 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

8. Chronic urticaria may not be as innocent as we think: A rare case of acquired cutis laxa following chronic urticaria

BOSTAN E., YALICI ARMAĞAN B., GÖKÖZ Ö.
JOURNAL OF COSMETIC DERMATOLOGY , cilt.21, sa.7, ss.3154-3156, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

9. Vesiculobullous Erythema Elevatum Diutinum: a Rare Variant With Epidermolysis Bullosa Acquisita-like Immunofluorescence Findings

YALICI ARMAĞAN B., ATEŞ ÖZDEMİR D., TERZİOĞLU H. G., Atakan N.
DERMATOLOGY PRACTICAL & CONCEPTUAL , cilt.12, sa.2, 2022 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

10. The effect of the COVID-19 pandemic on dermatology consultation requests from adult and paediatric emergency departments

DEMİREL ÖĞÜT N., Tabak G. H., GÜLSEREN BÜYÜKDOĞAN D., YALICI ARMAĞAN B., AKDOĞAN N., DOĞAN GÜNAYDIN S., et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , cilt.75, sa.12, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

11. Exacerbation of plaque psoriasis after inactivated and BNT162b2 mRNA COVID-19 vaccines: A report of two cases

BOSTAN E., Elmas L., Yel B., YALICI ARMAĞAN B.
DERMATOLOGIC THERAPY , cilt.34, sa.6, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

12. The effect of COVID-19 on patients with chronic spontaneous urticaria treated with omalizumab and antihistamines: A cross-sectional, comparative study

BOSTAN E., Zaid F., KARADUMAN A., DOĞAN GÜNAYDIN S., GÜLSEREN BÜYÜKDOĞAN D., YALICI ARMAĞAN B., et al.
JOURNAL OF COSMETIC DERMATOLOGY , cilt.20, sa.11, ss.3369-3375, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

13. Paediatric lichen sclerosus et atrophicus: A retrospective analysis of 38 paediatric patients

YALICI ARMAĞAN B., BOSTAN E., AKDOĞAN N., ERSOY EVANS S.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , cilt.75, sa.10, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

14. Treatment of psoriasis with biologics in the early COVID-19 pandemic: A study examining patient attitudes toward the treatment and disease course

YALICI ARMAĞAN B., Tabak G. H., DOĞAN GÜNAYDIN S., GÜLSEREN BÜYÜKDOĞAN D., AKDOĞAN N., Atakan N.
JOURNAL OF COSMETIC DERMATOLOGY , cilt.20, sa.10, ss.3098-3102, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

15. Yellow-white fluorescence on the nails: A novel finding of Favipiravir used for the treatment of COVID-19

GÜLSEREN BÜYÜKDOĞAN D., YALICI ARMAĞAN B.
JOURNAL OF COSMETIC DERMATOLOGY , cilt.20, ss.2392-2393, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

16. Severe hidradenitis suppurativa (acne inversa) associated with focal segmental glomerulosclerosis and gout partially responsive to canakinumab

AKDOĞAN N., YALICI ARMAĞAN B., DOĞAN GÜNAYDIN S., Yilmaz R.
DERMATOLOGIC THERAPY , cilt.34, sa.4, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

17. Vasculitis during certolizumab pegol and secukinumab treatment: Report of two cases

BOSTAN E., GÜLSEREN BÜYÜKDOĞAN D., YALICI ARMAĞAN B., DOĞAN GÜNAYDIN S., ATEŞ ÖZDEMİR D., GÖKÖZ Ö., et al.
DERMATOLOGIC THERAPY , cilt.34, sa.4, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

18. Herpes zoster following inactivated COVID-19 vaccine: A coexistence or coincidence?

BOSTAN E., YALICI ARMAĞAN B.
JOURNAL OF COSMETIC DERMATOLOGY , cilt.20, sa.6, ss.1566-1567, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

19. Age and psoriatic arthritis are important predictors of biologic agent switch in psoriasis

AKDOĞAN N., DOĞAN GÜNAYDIN S., BOSTAN E., GÜLSEREN BÜYÜKDOĞAN D., YALICI ARMAĞAN B., ELÇİN G., et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY , cilt.14, sa.12, ss.1535-1541, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

20. Dermoscopy of a rare case of proximal-type epithelioid sarcoma with oral mucosal and cutaneous metastasis

BOSTAN E., YALICI ARMAĞAN B., KÖSEMEHMETOĞLU K., ELÇİN G.
JOURNAL OF COSMETIC DERMATOLOGY , cilt.19, sa.12, ss.3441-3443, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

21. The decrease of demodex density after Nd:YAGlaser application for facial telengiactasias: A case report

YALICI ARMAĞAN B., ELÇİN G.
DERMATOLOGIC THERAPY , cilt.33, sa.6, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

22. Evaluation of microfocused ultrasound for improving skin laxity in the lower face: A retrospective study

YALICI ARMAĞAN B., ELÇİN G.
DERMATOLOGIC THERAPY , cilt.33, sa.6, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

23. Nasal Symptoms During Isotretinoin Therapy Can Be a Sign of Herpes Simplex Virus Infection

YALICI ARMAĞAN B., ERSOY EVANS S.
INFECTIOUS DISEASES IN CLINICAL PRACTICE , cilt.28, sa.6, 2020 (ESCI, Scopus) identifier identifier

24. Unusual presentation of basal cell carcinoma with fibroepithelioma-like histology in two patients with Gorlin syndrome

BOSTAN E., YALICI ARMAĞAN B., GÖKÖZ Ö., ELÇİN G.
INTERNATIONAL JOURNAL OF DERMATOLOGY , cilt.59, sa.5, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

25. A novel mutation of keratin 5 in epidermolysis bullosa simplex with migratory circinate erythema

YALICI ARMAĞAN B., Kabacam S., TAŞKIRAN Z. E., GÖKÖZ Ö., ÜTİNE G. E., ERSOY EVANS S.
PEDIATRIC DERMATOLOGY , cilt.37, sa.2, ss.358-361, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

26. Melanoma-like pigmented cutaneous metastasis of breast carcinoma

YALICI ARMAĞAN B., Demircan C., ELÇİN G.
INTERNATIONAL WOUND JOURNAL , cilt.16, sa.6, ss.1570-1571, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

27. New onset alopecia areata during secukinumab therapy

YALICI ARMAĞAN B., Atakan N.
DERMATOLOGIC THERAPY , cilt.32, sa.5, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

28. Targeted tumour therapy induced papulopustular rash and other dermatologic side effects: a retrospective study

YALICI ARMAĞAN B., Ayanoglu B. T., Demirdag H. G.
CUTANEOUS AND OCULAR TOXICOLOGY , cilt.38, sa.3, ss.261-266, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

29. Perceptions about oral isotretinoin treatment

Ayanoglu B. T., Demirdag H. G., YALICI ARMAĞAN B., Bezirgan O.
DERMATOLOGIC THERAPY , cilt.32, sa.3, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

30. Evaluation of hand-foot syndrome and hand-foot skin reaction: Case series

DEMİRDAG H. G., TUGRUL AYANOGLU B., YALICI ARMAĞAN B.
Turkderm-Archives Of The Turkish Dermatology And Venerology , cilt.53, sa.1, ss.28-31, 2019 (TRDizin)

31. Fractional carbon dioxide laser for facial rejuvenation: A prospective study to evaluate the efficacy and the safety

Yalici-Armagan B., Elcin G.
JOURNAL OF COSMETIC AND LASER THERAPY , cilt.20, sa.1, ss.2-8, 2018 (SCI-Expanded, Scopus) identifier identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 7

1. NADIR BIR OLGU: AKKIZ EPIDERMOLIZIS BÜLLOZA VE ERITEMA ELEVATUM DIUTINUM BIRLIKTELIGI

YETER H. G., ATEŞ ÖZDEMİR D., YALICI ARMAĞAN B., ATAKAN Z. N.
30. Ulusal Patoloji Kongresi, 20 Mayıs 2021, cilt.5, (Özet Bildiri)

2. Orta ve Şiddetli Psoriasisli Hastalarda Anti İnterlökin-17A (Sekukinumab) Tedavisi: Gerçek Yaşam Verileri

YALICI ARMAĞAN B., ATAKAN Z. N.
XXIV. Prof. Dr. A. Lütfü Tat Sempozyumu, Türkiye, 20 - 24 Kasım 2019, (Özet Bildiri)

3. Stevens Jonson and Toxic epidermal necrolysis: retrospective anlysis of 23 patients

demircan c., YALICI ARMAĞAN B., AKDOĞAN N., GÜLSEREN BÜYÜKDOĞAN D., DOĞAN GÜNAYDIN S., ELÇİN G., et al.
28th EADV congress, 9 - 13 Ekim 2019, (Özet Bildiri)

4. Correlation between laboratory parameters and disease stage in patients with mycosis fungoides

BOSTAN E., GÜLSEREN BÜYÜKDOĞAN D., DOĞAN GÜNAYDIN S., YALICI ARMAĞAN B., AKDOĞAN N., ERSOY EVANS S., et al.
28th EADV, 9 - 13 Ekim 2019, (Özet Bildiri)

5. MİKOZİS FUNGOİDESTE HASTALIK EVRESİ İLE LABORATUVAR PARAMETRELERİNİN İLİŞKİSİ

BOSTAN E., GÜLSEREN BÜYÜKDOĞAN D., DOĞAN GÜNAYDIN S., YALICI ARMAĞAN B., AKDOĞAN N., ERSOY EVANS S., et al.
28. ULUSAL DERMATOLOJİ KONGRESİ, Türkiye, 24 - 28 Eylül 2019, (Özet Bildiri)

6. STEVENS JOHNSON SENDROMU VE TOKSİK EPİDERMAL NEKROLİZ: 23 HASTANIN RETROSPEKTİF ANALİZİ

DEMİRCAN C., YALICI ARMAĞAN B., AKDOĞAN N., GÜLSEREN BÜYÜKDOĞAN D., DOĞAN GÜNAYDIN S., ELÇİN G., et al.
28. ULUSAL DERMATOLOJİ KONGRESİ, Türkiye, 24 - 28 Eylül 2019, (Özet Bildiri)

7. Dermatolojik Hastalıkların Dermatologlar ve Yakınları Arasındaki Sıklığı ile Uzmanlık AlanıSeçimi Üzerine Etkisini Değerlendiren Anket Çalışması

YALICI ARMAĞAN B., DOĞAN GÜNAYDIN S., DEMİRCAN C., ATAKAN Z. N., ERSOY EVANS S.
DERMATOLOJİDE VE KOZMETOLOJİDEGELİŞMELER KONGRESİ, Türkiye, 22 - 26 Mayıs 2019, (Özet Bildiri)
Metrikler

Yayın

41

Yayın (WoS)

31

Yayın (Scopus)

32

Atıf (WoS)

136

H-İndeks (WoS)

5

Atıf (Scopus)

155

H-İndeks (Scopus)

5

Atıf (Scholar)

2

H-İndeks (Scholar)

1

Proje

2

Açık Erişim

5
BM Sürdürülebilir Kalkınma Amaçları